---
figid: PMC8593140__40487_2021_153_Fig1_HTML
figtitle: How to Optimise Extended Adjuvant Treatment with Neratinib for Patients
  with Early HER2+ Breast Cancer
organisms:
- Oryza sativa
- Malus domestica
- Musa acuminata
- Citrus x paradisi
- Homo sapiens
- unidentified
organisms_ner:
- Drosophila melanogaster
pmcid: PMC8593140
filename: 40487_2021_153_Fig1_HTML.jpg
figlink: /pmc/articles/PMC8593140/figure/Fig1/
number: F1
caption: Mechanism of action of neratinib on the HER2 pathway. ER oestrogen receptor;
  HER human epidermal growth factor receptor; HER2 human epidermal growth factor receptor
  2. Figure reproduced with permission of Pierre Fabre
papertitle: How to Optimise Extended Adjuvant Treatment with Neratinib for Patients
  with Early HER2+ Breast Cancer.
reftext: Michael Untch, et al. Oncol Ther. 2021 Dec;9(2):297-309.
year: '2021'
doi: 10.1007/s40487-021-00153-5
journal_title: Oncology and Therapy
journal_nlm_ta: Oncol Ther
publisher_name: Springer Healthcare
keywords: Adjuvant treatment | Early breast cancer | Efficacy | Extended treatment
  | Human epidermal growth factor receptor 2-positive | Hormone receptor-positive
  | Neratinib | Tolerability | Trastuzumab | Tyrosine kinase inhibitor
automl_pathway: 0.9468048
figid_alias: PMC8593140__F1
figtype: Figure
redirect_from: /figures/PMC8593140__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8593140__40487_2021_153_Fig1_HTML.html
  '@type': Dataset
  description: Mechanism of action of neratinib on the HER2 pathway. ER oestrogen
    receptor; HER human epidermal growth factor receptor; HER2 human epidermal growth
    factor receptor 2. Figure reproduced with permission of Pierre Fabre
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - her
  - Hesr
  - ww
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
---
